EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test‐Based Organized Screening Program in Italy: A Randomized Control Trial

Cristiano Spada iD, Paola Cesaro iD, Lorenzo Fuccio iD, Daniele Salvi iD, Clarissa Ferrari iD, Federico Barbaro, Alessandra Bizzotto, Francesco Butitta iD, Viviana Gerardi iD, Mauro Lovera, Sebastian Manuel Milluzzo iD, Leonardo Minelli Grazioli iD und 10 weitere

United European Gastroenterology Journal · 2026

DOI: 10.1002/ueg2.70176 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift United European Gastroenterology Journal, 2026. Verfasst von Cristiano Spada und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Endoscopy, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy. Hauptthemen laut MEDLINE: Occult Blood, Early Detection of Cancer, Adenoma, Colorectal Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The fecal immunochemical test (FIT) is widely implemented as a first‐line tool in organized colorectal cancer (CRC) screening programs, including Italy. Following a positive FIT, colonoscopy is recommended. Computer‐aided detection (CADe) systems have the potential to enhance adenoma detection, particularly in FIT‐positive populations where identifying advanced adenomas is critical for cancer prevention. This study evaluated the diagnostic performance of CADe‐assisted colonoscopy versus standard colonoscopy (SC) in a FIT‐based screening cohort.

Methods

In this multicenter, randomized controlled trial, patients with a positive FIT result were randomized to undergo either CADe‐assisted or standard colonoscopy. The primary endpoint was the advanced adenoma detection rate (AADR). Secondary endpoints included overall adenoma detection rate (ADR), adenomas per colonoscopy (APC), and mean withdrawal time (WT).

Results

Of 1077 patients enrolled, 68 were excluded due to inadequate bowel preparation, leaving 1009 patients for analysis (CADe: n = 506; SC: n = 503). AADR was comparable between the groups (21.3% vs. 20.5%, p = 0.794). However, CADe significantly improved ADR (67.6% vs. 59.8%, p = 0.012) and APC (1.82 ± 2.12 vs. 1.34 ± 1.81, p < 0.001). Mean WT was longer in the CADe group (17.10 ± 8.28 min vs. 16.13 ± 8.28 min, p = 0.016).

Conclusions

In a FIT‐based organized CRC screening setting, CADe did not enhance detection of AADR with a modest increase in withdrawal time. NCT04441580.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Occult BloodEarly Detection of CancerAdenomaColorectal NeoplasmsPrecancerous ConditionsArtificial IntelligenceHumansFemaleMaleColonoscopyItalyMiddle AgedAgedMass ScreeningFeces

Autor:innen und Institutionen

  • Department of Gastroenterology and Endoscopy, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.
  • Digestive Endoscopy Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna Policlinico S Orsola-Malpighi, Bologna, Italy.
  • Research and Clinical Trials Unit, Fondazione Poliambulanza Istituto Ospedaliero, Brescia, Italy.

ORCID-Profile: Cristiano Spada, Paola Cesaro, Lorenzo Fuccio, Daniele Salvi, Clarissa Ferrari, Francesco Butitta, Viviana Gerardi, Sebastian Manuel Milluzzo, Leonardo Minelli Grazioli, Nicola Olivari, Silvia Pecere, Stefania Piccirelli, Cecilia Lina Pugliano, Alessandro Quadarella, Enrico Tettoni, Chiara Zani, Luigi Ricciardiello, Guido Costamagna

Zitieren

APA

Spada, C., Cesaro, P., Fuccio, L., Salvi, D., Ferrari, C., Barbaro, F., Bizzotto, A., Butitta, F., Gerardi, V., Lovera, M., Milluzzo, S. M., Minelli Grazioli, L., Olivari, N., Pecere, S., Piccirelli, S., Pugliano, C. L., Pesatori, E. V., Quadarella, A., Tettoni, E., …, & Costamagna, G. (2026). Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test‐Based Organized Screening Program in Italy: A Randomized Control Trial. United European Gastroenterology Journal. https://doi.org/10.1002/ueg2.70176

Vancouver

Spada C, Cesaro P, Fuccio L, Salvi D, Ferrari C, Barbaro F, et al. Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test‐Based Organized Screening Program in Italy: A Randomized Control Trial. United European Gastroenterology Journal. 2026. doi:10.1002/ueg2.70176

BibTeX
@article{Spada2026,
  author = {Spada, Cristiano and Cesaro, Paola and Fuccio, Lorenzo and Salvi, Daniele and Ferrari, Clarissa and Barbaro, Federico and Bizzotto, Alessandra and Butitta, Francesco and Gerardi, Viviana and Lovera, Mauro and Milluzzo, Sebastian Manuel and Minelli Grazioli, Leonardo and Olivari, Nicola and Pecere, Silvia and Piccirelli, Stefania and Pugliano, Cecilia Lina and Pesatori, Eugenia Vittoria and Quadarella, Alessandro and Tettoni, Enrico and Zani, Chiara and Ricciardiello, Luigi and Costamagna, Guido},
  title = {Impact of Artificial Intelligence for Detection of Precancerous Colonic Lesions in a Fecal Immunochemical Blood Test‐Based Organized Screening Program in Italy: A Randomized Control Trial},
  journal = {United European Gastroenterology Journal},
  year = {2026},
  doi = {10.1002/ueg2.70176}
}
Kostenlos starten →